Page last updated: 2024-09-02

fingolimod hydrochloride and Thrombocytopenia

fingolimod hydrochloride has been researched along with Thrombocytopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brait, VH; Chamorro, A; Gallizioli, M; Justicia, C; Meissner, A; MirĂ³-Mur, F; Planas, AM; Salas-Perdomo, A; Urra, X1

Other Studies

1 other study(ies) available for fingolimod hydrochloride and Thrombocytopenia

ArticleYear
Role of the S1P pathway and inhibition by fingolimod in preventing hemorrhagic transformation after stroke.
    Scientific reports, 2019, 06-05, Volume: 9, Issue:1

    Topics: Animals; Brain; Brain Ischemia; Fingolimod Hydrochloride; Hemoglobins; Hemorrhage; Lymphocytes; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myeloid Cells; Reperfusion Injury; RNA, Messenger; Sphingosine; Sphingosine 1 Phosphate Receptor Modulators; Sphingosine-1-Phosphate Receptors; Stroke; T-Lymphocytes; Thrombocytopenia; Up-Regulation

2019